Six days following treatment with either Tx + ɑCD4 or ɑCD4, we observed increased CD8+ T cells infiltrating the tumor (Fig. 2i), which is in agreement with the enhanced activation state observed in the TdLN (Fig. 2e–h). This evidence concerns the gene CD8A and neoplasm.